Submission Deadline 06/15/2028
Fiscal Capacity $50,135,013
HHS-NIH11 Grant — Key Facts
Opportunity Number RFA-OD-27-005
Agency HHS-NIH11
Application Deadline 06/15/2028
Award Amount $50,135,013
Status Posted
Sector Health
Cost Sharing Not Required

Fiscal Parameters & Taxonomy

Authority HHS-NIH11
Status Posted

Who Can Apply

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Independent school districts Others (see text field entitled "Additional Information on Eligibility" for clarification) City or township governments County governments Native American tribal governments (Federally recognized) Special district governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses

Eligibility Intelligence

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Program Description

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. The purpose of this Notice of Funding Opportunity (NOFO) encourages Exploratory/Developmental Phased Innovation (R61/R33) grant applications to support development of clinical trials to treat critical and co-occurring health conditions in individuals with Down syndrome. The proposed research aims should be milestone-driven. The total project period for an application submitted in response to this NOFO may not exceed five years. This NOFO provides support for up to two years (R61 phase) for preliminary/developmental/planning studies, followed by possible transition to clinical trial support (R33) of up to three years, although the total duration of the award may not exceed five years. This NOFO requires measurable R61 milestones.

CFDA Programs

93.173 Research Related to Deafness and Communication Disorders
93.233 National Center on Sleep Disorders Research
93.310 Trans-NIH Research Support
93.350 National Center for Advancing Translational Sciences
93.395 Cancer Treatment Research
93.837 Cardiovascular Diseases Research
93.838 Lung Diseases Research
93.839 Blood Diseases and Resources Research
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
93.846 Arthritis, Musculoskeletal and Skin Diseases Research
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
93.865 Child Health and Human Development Extramural Research
93.866 Aging Research

Agency Contact

The INCLUDE Project DownSyndromeINCLUDE@mail.nih.gov

✉ DownSyndromeINCLUDE@mail.nih.gov

📞 301-402-2541

Related Intelligence Guides

In-depth editorial guides covering this agency's programs, eligibility requirements, and application strategies.

GrantMetric Intelligence Systems — Independent federal grant intelligence platform. Not affiliated with Grants.gov, the U.S. Department of Health & Human Services, or any government agency. Grant data is sourced from the Grants.gov API for informational purposes only; always verify opportunity details directly with the funding agency before applying. Some links on this site are affiliate links — we may earn a commission at no additional cost to you. Full Disclaimer  ·  Last Reviewed: May 2026  ·  Data Methodology